These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 2484294)
1. Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy. Donaldson SS; Link MP; McDougall IR; Parker BR; Shochat SJ Cancer Treat Res; 1989; 41():307-15. PubMed ID: 2484294 [No Abstract] [Full Text] [Related]
2. Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Canellos GP Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509 [TBL] [Abstract][Full Text] [Related]
3. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results. Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855 [No Abstract] [Full Text] [Related]
4. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M; J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458 [TBL] [Abstract][Full Text] [Related]
5. Should MOPP-ABVD alone be standard for childhood Hodgkin's? Constine LS J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214 [No Abstract] [Full Text] [Related]
6. Pediatric Hodgkin's disease. Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795 [TBL] [Abstract][Full Text] [Related]
7. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060 [TBL] [Abstract][Full Text] [Related]
8. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD? Canellos GP Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055 [No Abstract] [Full Text] [Related]
9. [Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation]. Leverger G; Oberlin O; Schaison G; Lemerle J Nouv Rev Fr Hematol (1978); 1987; 29(1):83-5. PubMed ID: 2438648 [TBL] [Abstract][Full Text] [Related]
10. [Controversy regarding the treatment of Hodgkin's disease]. Balwierz W; Armata J Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966 [No Abstract] [Full Text] [Related]
11. MOPP, ABVD, or both to treat Hodgkin's disease. Aisenberg AC N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765 [No Abstract] [Full Text] [Related]
12. MOPP, ABVD, or both to treat Hodgkin's disease. Martino R; Nomdedeu J; Brunet S N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766 [No Abstract] [Full Text] [Related]
13. [The management of Hodgkin's disease with chemotherapy or combined modality treatment]. Tsushita K; Utsumi M; Shimoyama M Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076 [TBL] [Abstract][Full Text] [Related]
14. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496 [TBL] [Abstract][Full Text] [Related]
15. [Improved survival rates in Hodgkin's disease]. Hayabuchi N; Jingu K; Miyoshi M; Hirata H; Masuda K; Shibuya T; Nishimura J; Komiyama S; Ishii E; Kikuchi M Gan No Rinsho; 1988 Apr; 34(5):698-704. PubMed ID: 2455073 [TBL] [Abstract][Full Text] [Related]
16. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107 [TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced Hodgkin's disease. Straus DJ Hematol Oncol Clin North Am; 1989 Jun; 3(2):287-302. PubMed ID: 2473061 [TBL] [Abstract][Full Text] [Related]
18. [Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol]. GabryĆ K; Kotlarek-Haus S; Sciborski R Pol Tyg Lek; 1986 Feb; 41(7):195-8. PubMed ID: 2423994 [No Abstract] [Full Text] [Related]
19. MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians. Andrieu JM; Yilmaz U; Colonna P J Clin Oncol; 1999 Feb; 17(2):730-4. PubMed ID: 10080622 [No Abstract] [Full Text] [Related]
20. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]